Free Trial

Mindflair (MFAI) Competitors

GBX 0.70 0.00 (0.00%)
(As of 12/20/2024 10:57 AM ET)

MFAI vs. BPCR, KRM, WINV, SVCT, USG, PU12, CYS, GV1O, TV2H, and ALGW

Should you be buying Mindflair stock or one of its competitors? The main competitors of Mindflair include BioPharma Credit (BPCR), KRM22 (KRM), Worsley Investors (WINV), Seneca Growth Capital VCT (SVCT), Ultimate Sports Group (USG), Puma VCT 12 (PU12), Chrysalis VCT (CYS), Gresham House Renewable Energy VCT 1 (GV1O), Thames Ventures VCT 2 Healthcare Shs (TV2H), and Alpha Growth (ALGW). These companies are all part of the "asset management" industry.

Mindflair vs.

BioPharma Credit (LON:BPCR) and Mindflair (LON:MFAI) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

BioPharma Credit has a net margin of 79.90% compared to Mindflair's net margin of 0.00%. BioPharma Credit's return on equity of 8.10% beat Mindflair's return on equity.

Company Net Margins Return on Equity Return on Assets
BioPharma Credit79.90% 8.10% 4.98%
Mindflair N/A -6.88%-2.90%

In the previous week, BioPharma Credit's average media sentiment score of 0.00 equaled Mindflair'saverage media sentiment score.

Company Overall Sentiment
BioPharma Credit Neutral
Mindflair Neutral

BioPharma Credit has higher revenue and earnings than Mindflair. Mindflair is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioPharma Credit£135.74M0.08£108.45M£0.0810.63
MindflairN/AN/AN/A-£0.01-70.00

BioPharma Credit has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Mindflair has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

BioPharma Credit received 84 more outperform votes than Mindflair when rated by MarketBeat users.

CompanyUnderperformOutperform
BioPharma CreditOutperform Votes
84
64.62%
Underperform Votes
46
35.38%
MindflairN/AN/A

41.5% of BioPharma Credit shares are held by institutional investors. 6.2% of BioPharma Credit shares are held by company insiders. Comparatively, 14.0% of Mindflair shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

BioPharma Credit beats Mindflair on 8 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MFAI vs. The Competition

MetricMindflairAsset Management IndustryFinancial SectorLON Exchange
Market Cap£2.57M£1.09B£3.73B£1.92B
Dividend YieldN/A4.69%4.43%5.45%
P/E Ratio-70.00802.21418.741,880.82
Price / SalesN/A1,455.431,744.90397,035.90
Price / CashN/A64.7652.5328.78
Price / Book0.231.141.372.81
Net IncomeN/A£64.95M£361.47M£156.11M
7 Day Performance-3.45%-1.95%-1.62%-2.03%
1 Month Performance-17.65%-0.25%0.23%21.85%
1 Year PerformanceN/A7.22%9.87%30.10%

Mindflair Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MFAI
Mindflair
N/AGBX 0.70
flat
N/AN/A£2.57MN/A-70.003Gap Down
High Trading Volume
BPCR
BioPharma Credit
N/AGBX 0.88
+0.9%
N/A-2.1%£10.54M£135.74M10.88N/A
KRM
KRM22
N/AGBX 28.50
flat
N/AN/A£10.23M£6.16M-285.0045
WINV
Worsley Investors
N/AGBX 29.76
-0.1%
N/A+14.3%£10.04M£742,000.001,023.332
SVCT
Seneca Growth Capital VCT
N/AGBX 49.50
flat
N/AN/A£9.89M£-2,610,000.00-777.78N/A
USG
Ultimate Sports Group
N/AGBX 27.50
+5.8%
N/AN/A£9.78M£1.69M-68.7591Gap Up
PU12
Puma VCT 12
N/AGBX 24
flat
N/AN/A£9.25M£5.99M141.18N/A
CYS
Chrysalis VCT
N/AGBX 32.50
flat
N/AN/A£9.25M£789,000.0065.0017
GV1O
Gresham House Renewable Energy VCT 1
N/AGBX 35
flat
N/AN/A£8.93MN/A1,750.00N/A
TV2H
Thames Ventures VCT 2 Healthcare Shs
N/AGBX 37.50
+2.7%
N/AN/A£8.83MN/A-1,875.00N/AGap Up
ALGW
Alpha Growth
N/AGBX 1.81
-4.7%
N/A-20.9%£8.47M£5.52M-7.434Positive News
Gap Up

Related Companies and Tools


This page (LON:MFAI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners